Our CEO, Mark McDonough, engaged in an insightful discussion with Jeff Harmon of 'Conversations Life Science Leaders Aren't Having' and Russo Partners, shedding light on effective collaboration with investors. #Biotech #Innovation #JPM2024 #Genomics

Recently we announced the following changes to our Board of Directors: ➡Mark McDonough, ChromaCode CEO, was appointed Chairman ➡ Former Chair, Carol Gallagher, Pharm.D., retired from the board ➡ Michele Park, Ph.D., was appointed to the board prnewswire.com/news-releases/…

#MeetTheTeam – Crane Harris, our VP of corporate development, brings extensive experience working for #genomic companies to ChromaCode. He is passionate about developing #collaborations that allow us to further develop our #HDPCR technologies. chromacode.com/leadership-tea…

Our CBO, Padma Sundar, is speaking at Precision Medicine World Conference about using our #HDPCR assay as an alternative for high TAM applications for applications which might otherwise require #NGS, as part of the #PMWC24’s Showcase Track S2: Clinical Dx/Tools Track. pmwcintl.com/speaker/padma-…

Don’t miss TODAY’S presentation by our CBO, Padma Sundar, who is speaking about using our #HDPCR assay for high TAM applications which might otherwise require #NGS, as part of Precision Medicine World Conference’s Showcase Track S2: Clinical Dx/Tools Track. pmwcintl.com/speaker/padma-… #PMWC24 #genomics

We’re proud to announce the publication of a study in the scientific journal Diagnostics demonstrating that our #HDPCR #NSCLC assay outperforms #NGS in cases where there is low sample input. Learn more: prn.to/48PDBfV #Oncology #Innovation #Publication #Genetics

Our #HDPCR assay for #NSCLC has faster turn-around times compared to #NGS and more comprehensive results compared to standard #dPCR. Check it out: chromacode.com/oncology/

#ICYMI – Mark McDonough, ChromaCode’s CEO, was recently featured on DocWire News, where he spoke about our #HDPCR technology and the need for our #NSCLC assay. docwirenews.com/post/a-rapid-d… #genetics #oncology #leadership #dPCR

Today is #WorldCancerDay, a day to recognize the high toll that cancer takes around the world. Because of a lack of accessibility, many people around the world aren’t able to receive the most effective cancer treatments. worldcancerday.org #CloseTheCareGap World Cancer Day

It was great seeing everyone at Precision Medicine World Conference! We had an excellent time speaking with our colleagues in the #precisionmedicine space. Special thanks to everyone who came to our workshop and made it successful! #Oncology #Genomics #dPCR

#MeetTheTeam – Brett Brown, our VP of Finance and Administration, has over twenty years of experience in finance, corporate management, and human resources. chromacode.com/leadership-tea… #genetics #oncology #leadership #dPCR

Did you know our cloud analysis platform recently got an upgrade? ChromaCode Cloud 6.1 represents a significant leap forward in our commitment to enhancing our cutting-edge #genomics solutions. bit.ly/48eMUoS #dPCR #Oncology #Innovation

In this continuing series 'Conversations Life Science Leaders Aren't Having,' hear our Chairman & CEO Mark McDonough on ChromaCode, Inc.’s growth discipline in today’s challenging environment. #Biotech #Innovation #JPM2024 #Genomics x.com/russopartners/…

First in Human podcast by Vial features Mark McDonough of ChromaCode, Inc. on the impact of early detection on disease outcomes. From military to Chairman & CEO, hear how he's leading change in genomics. bit.ly/49SQuWW #Innovation #Genomics

🎧 Listen to the Medtech Insight, Citeline Commercial podcast featuring ChromaCode, Inc.'s Mark McDonough, discussing the innovative genomic solutions they're developing to facilitate targeted treatment of cancer. More here: bit.ly/4bZ7ZXj #HealthcareInnovation #Cancer

#ICYMI: Mark McDonough of ChromaCode, Inc. discusses the game changing HDPCR tech with Medical Device & Technology. By bridging the gap in genomics, ChromaCode strives to deliver cost-effective solutions that more quickly deliver results. For more: bit.ly/3IoqkPY #HealthTech #Genomics

In the continuing series 'Conversations Life Science Leaders Aren't Having,' hear our Chairman & CEO Mark McDonough highlight ChromaCode, Inc.’s pivotal role in enhancing investor confidence. #Biotech #Innovation #JPM2024 #Genomics x.com/russopartners/…

🧬 Genetic testing for cancer risk is becoming more affordable, thanks to firms like ChromaCode. Learn how advancements in genetic screening, as reported by NPR's Nell Greenfieldboyce, are saving lives. n.pr/45c2v7j #GeneticTesting

In this story in Technology Networks originally by @UCDavis, Innovative blood tests can spot cancer 18 months before CT scans, highlighting the value of technologies such as ChromaCode develops. For more: bit.ly/495d1Pd #HealthTech #HealthInnovation